文献速递主动脉外科

肌少症对肾下腹主动脉瘤微创手术或腔内修复术后1年结局的预测作用

Role of Sarcopenia in Predicting 1-Year Outcomes After Mini-invasive Surgical or Endovascular Repair of Infrarenal Abdominal Aortic Aneurysms.
PubMed 文献 · Eur J Cardiothorac Surg · 2025-01-01

本研究回顾性纳入403例择期治疗肾下腹主动脉瘤的衰弱患者,其中122例(30.3%)存在肌少症(nTPA<500 mm²/m²)。比较EVAR(272例)与开放手术(OSER,131例)的结局,发现两组术中及术后结局无显著差异,但肌少症患者接受OSER后1个月及累积随访的全因死亡率显著更高。提示对肌少症患者EVAR可能作为优先策略。

要点

  • 肌少症(nTPA<500 mm²/m²)在衰弱腹主动脉瘤患者中占30.3%。
  • EVAR与OSER在术中及术后结局无显著差异, mortality和再干预率亦无差异。
  • 肌少症患者接受OSER后1个月及累积全因死亡率显著更高。

核心结论

  • 微创入路(手术或腔内)对腹主动脉瘤患者可行,术中及术后早期结局无显著差异。
  • 基于明确肌少症的衰弱患者,EVAR可作为优先策略考虑。

研究设计与样本

  • 回顾性研究,纳入403例择期治疗的肾下腹主动脉瘤衰弱患者。
  • 衰弱定义为标准化总腰大肌面积(nTPA)<500 mm²/m²;其中122例(30.3%)为肌少症。
  • 272例(67.5%)接受EVAR,131例(32.5%)接受开放手术(OSER)。

主要发现

  • 肌少症患者中EVAR较OSER更常实施(P<0.001)。
  • 两组术中及术后结局无显著差异。
  • Kaplan-Meier分析显示两组死亡率和再干预率无统计学显著差异。
  • 肌少症患者接受OSER后1个月全因死亡率显著更高(P=0.031),累积随访全因死亡率亦显著更高(P=0.004)。

关键数值与推荐

  • 衰弱定义:nTPA<500 mm²/m²。
  • 肌少症患者OSER后1个月全因死亡率P=0.031,累积随访P=0.004。

临床怎么用

  • 对腹主动脉瘤患者应评估肌少症(nTPA<500 mm²/m²)以识别衰弱。
  • 肌少症患者行OSER时需警惕1个月及累积全因死亡率升高,EVAR可优先考虑。

局限性

  • 回顾性研究设计。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the outcome of frail patients electively treated for abdominal aortic aneurysm (AAA) by open surgery with enhanced repair protocol (OSER) or endovascular aneurysm repair (EVAR). DESIGN: A retrospective study on frail AAA patients treated by EVAR and OSER was conducted. Patients were defined as frail if they present a normalized total psoas muscle area (nTPA) <500 mm2/m2. This study aimed to evaluate the association between sarcopenia and AAA-related as well as all-cause mortality rates. Secondary outcomes included reinterventions, operative time, blood transfusion, length of intensive care unit (ICU), and postoperative hospital stay. RESULTS: A total of 403 patients were included in the study, of which 122 (30.3%) had a nTPA < 500mm2/m2. Among them, 272 (67.5%) patients were treated with EVAR while 131 (32.5%) with OSER. Although EVAR was more frequently performed in sarcopenic patients than OSER (P<0.001), there were no significant differences between the 2 groups in terms of intraoperative and postoperative outcomes. Likewise, no statistically significant differences were found regarding mortality and reintervention rates at Kaplan-Meier analysis. However, sarcopenic patients undergoing OSER exhibited a significantly higher all-cause mortality rate at 1 month (P = 0.031) and cumulative follow-up (P = 0.004) compared to all other subgroups. CONCLUSIONS: The present experience demonstrates that less invasive approaches, but surgical or endovascular, are viable for AAA patients with no significant difference in intraoperative and immediate postoperative outcomes. Nevertheless, the potential of EVAR as a preferred strategy should be considered for frail patients based on ascertained sarcopenia.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Sirignano P, Barillà D, Colonna G, et al. Role of Sarcopenia in Predicting 1-Year Outcomes After Mini-invasive Surgical or Endovascular Repair of Infrarenal Abdominal Aortic Aneurysms. Eur J Cardiothorac Surg. 2025. PMID: 40680178. doi:10.1093/ejcts/ezaf241

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。